A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
D000998:Antiviral Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D015683:Gene Products, gag / Q000096:biosynthesis / Q000378:metabolism; D015488:HIV Antigens / Q000096:biosynthesis; D016655:HIV Core Protein p24; D017320:HIV Protease Inhibitors; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D009842:Oligopeptides / Q000494:pharmacology*; D011498:Protein Precursors / Q000378:metabolism; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D014758:Viral Core Proteins / Q000096:biosynthesis; D014764:Viral Proteins; D014779:Virus Replication / Q000187:drug effects*; D054301:gag Gene Products, Human Immunodeficiency Virus
D000998:Antiviral Agents; D015683:Gene Products, gag; D015488:HIV Antigens; D016655:HIV Core Protein p24; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011498:Protein Precursors; D011993:Recombinant Fusion Proteins; D014758:Viral Core Proteins; D014764:Viral Proteins; D054301:gag Gene Products, Human Immunodeficiency Virus; C054858:p17 protein, Human Immunodeficiency Virus Type 1; C059767:p55 gag precursor protein, Human immunodeficiency virus 1; C062520:U 81749